Hydroxychloroquine reduces viral load in COVID-19 patients
…small clinical trial has revealed it to be effective in reducing viral loads in COVID-19 patients. Entry of enveloped viruses into cells requires fusion of viral and cell membranes to…
…small clinical trial has revealed it to be effective in reducing viral loads in COVID-19 patients. Entry of enveloped viruses into cells requires fusion of viral and cell membranes to…
…through human phase I trials, and stockpiled for the next pandemic. But there was no money to support such work – neither in the halls of big Pharma or forthcoming…
by Helen Stillwell The results from a phase I clinical trial to test the safety and immunogenicity of a universal flu vaccine candidate reported encouraging results €“ strong titers of…
…it made fewer copying errors and had reduced recombination frequency. The resulting nOPV2 was tested extensively in cells in culture and in experimental animals to demonstrate that the virus did…
…prevent microbial contamination. The results of several large epidemiological studies found no connection between autism and thimerosal. Nevertheless, the preservative was removed from most childhood vaccines – probably an error,…
…JCV, 15% for LPV, 55% for KIV, 69% for WUV, and 25 and 42% for two different MCV strains. The sampling error is plus or minus 1%. Seroprevalence of these…